LENZ Therapeutics, Inc. SEC filings LENZ
LENZ Therapeutics, Inc. has 359 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, exit or restructuring costs, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 4, 2026 | — |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 2, 2026 | — |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Oct 28, 2026 | Oct 28, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 8, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 26, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 12, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 8, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 7, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 7, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 17, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 8, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 22, 2025 | — |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 20, 2025 | — |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 14, 2025 | — |
| 4 | Insider transaction | Jul 14, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 12, 2025 | — |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2025 | Jun 10, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 9, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Apr 15, 2025 | Apr 15, 2025 |
| EFFECT | Filing | Apr 14, 2025 | — |
| EFFECT | Filing | Apr 14, 2025 | — |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| 424B3 | Prospectus | Apr 14, 2025 | — |
| CORRESP | Letter to the SEC | Apr 10, 2025 | — |
| CORRESP | Letter to the SEC | Apr 10, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| 4 | Insider transaction | Apr 9, 2025 | Apr 9, 2025 |
| 424B3 | Prospectus | Apr 9, 2025 | — |
| 424B3 | Prospectus | Apr 9, 2025 | — |
| EFFECT | Filing | Apr 8, 2025 | — |
| EFFECT | Filing | Apr 8, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 4, 2025 | Apr 4, 2025 |
| S-3 | Shelf registration | Apr 4, 2025 | — |
| S-3 | Shelf registration | Apr 4, 2025 | — |
| POS AM | Filing | Apr 4, 2025 | — |
| POS AM | Filing | Apr 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 8, 2024 | — |
| 424B3 | Prospectus | Nov 6, 2024 | — |
| 424B3 | Prospectus | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 424B3 | Prospectus | Oct 28, 2024 | — |
| 424B3 | Prospectus | Oct 28, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 28, 2024 | Oct 27, 2024 |
| EFFECT | Filing | Sep 19, 2024 | — |
| 424B3 | Prospectus | Sep 19, 2024 | — |
| CORRESP | Letter to the SEC | Sep 17, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2024 | — |
| S-1 | Registration statement | Sep 11, 2024 | — |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| SC 13G | Ownership over 5% (passive) | Jul 29, 2024 | — |
| 4 | Insider transaction | Jul 23, 2024 | Jul 22, 2024 |
| 424B3 | Prospectus | Jul 15, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 15, 2024 | Jul 14, 2024 |
| S-8 | Employee stock plan registration | May 21, 2024 | — |
| 4 | Insider transaction | May 15, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 13, 2024 |
| 424B3 | Prospectus | May 9, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 424B3 | Prospectus | Apr 11, 2024 | — |
| EFFECT | Filing | Apr 10, 2024 | — |
| S-1/A | Amended registration statement | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 8, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 3, 2024 | Apr 3, 2024 |
| S-1 | Registration statement | Mar 29, 2024 | — |
| 3 | Initial insider ownership | Mar 28, 2024 | Mar 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 28, 2024 | — |
| SC 13D | Ownership over 5% (active) | Mar 28, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 25, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 25, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 25, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 22, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 14, 2024 | Mar 14, 2024 |
| 425 | Filing | Mar 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 8, 2024 | Mar 8, 2024 |
| 425 | Filing | Mar 5, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 5, 2024 | Mar 5, 2024 |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| SEC STAFF LETTER | Filing | Feb 13, 2024 | — |
| EFFECT | Filing | Feb 13, 2024 | — |
| 424B3 | Prospectus | Feb 13, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| S-4/A | Filing | Feb 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 5, 2024 | — |
| S-4/A | Filing | Feb 5, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- LENZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1815776
- Former names
- Graphite Bio, Inc. (until Mar 19, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.